Adalta Ltd has released a press release.
Commercialisation Agreement with Crossbeta Biosciences
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AdAlta
- Quarterly Review and Appendix 4C
- Receipt of Innovation Connections Grant
- Agreement with FujiFilm Diosynth Biotechnologies
Later from AdAlta
- Positive Pre-clinical Data
- AdAlta receives Orphan Designation for AD-114
- AdAlta expands partnership with Alfred Hospital
- Presentation of Eye Fobrosis Data at ARVO Meeting
- Toxicology study and manufacturing update
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta